Skip to main content
. Author manuscript; available in PMC: 2020 Jan 2.
Published in final edited form as: Org Lett. 2008 Oct 29;10(22):5155–5158. doi: 10.1021/ol8020989

Table 2.

Nitric oxide release, fluorescence measurements, and in vitro anti-proliferative activity

compd nitric oxide yield (%)a fluorescencec ± S. D.d (a.u.) relative fluorescence (%) IC50 (μM)e
DMSO 0 7.7 ± 0.25 100 -
2 100 9.5 ± 0.13 124 >20f
3 87b 7.9 ± 0.09 103 9.6g
4 96 7.4 ± 0.18 96 >20
5 98 17.0 ± 0.49 221 5.4
6 100b 28.9 ± 1.26 375 2.7
7 100 17.0 ± 0.49 221 6.0
8 100 24.3 ± 0.85 315 3.4
9 100 26.7 ± 0.85 346 4.8
10 99 24.9 ± 0.70 324 1.4
a

Nitric oxide yields from the decomposition of the compound (50-100 μL of a 0.1 mM DMSO solution) in the presence of GSH (3.6 mM) in 0.1 M phosphate buffer (3.5 mL) containing 50 μM diethylenetriamine pentaacetic acid (DTPA) at pH 7.4 and 37 °C as measured by chemiluminescence.

b

Calculated based on 4 moles of NO per mole of compound.

c

Mean intracellular NO release measured using the NO-sensitive DAF-FM diacetate dye in HL-60 cells measured in arbitrary units (a.u.).

d

Standard deviations of fluorescence measurements (3 independent experiments).

e

The 50% inhibitory concentrations are reported for activity against proliferation of HL-60 cells.